Position in NVCR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,149,785
+$822,165 QoQ
Shares Held
141,900
+16.5% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#64
of 217 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $27,654,363 across 8 Medical Devices names. NVCR ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
907,739 | $8,569,056 | |
| 2 | TXG |
10x Genomics, Inc.
|
216,200 | $8,289,108 | |
| 3 | INFU |
InfuSystem Holdings, Inc
|
424,473 | $4,096,164 | |
| 4 | VMD |
Viemed Healthcare, Inc.
|
225,109 | $2,566,242 | |
| 5 | NVCR |
NovoCure Ltd
This page
|
141,900 | $2,149,785 | |
| 6 | ABT |
Abbott Laboratories
|
9,100 | $825,734 | |
| 7 | APYX |
Apyx Medical Corp
|
182,600 | $819,874 | |
| 8 | ELMD |
Electromed, Inc.
|
8,000 | $338,400 |
All Filings in NVCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,149,785 | 141,900 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,327,620 | 121,800 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,704,174 | 131,800 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,702,856 | 131,800 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,490,220 | 139,900 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,439,558 | 136,900 | Shares | Sole | 2025-05-09 | |
| 2020-06-30 | $610,790 | 10,300 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $693,602 | 10,300 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||